spacer
home > epc > spring 2002 > stem cells - the clinician's 'philosopher's stone'
PUBLICATIONS
European Pharmaceutical Contractor

Stem Cells - The Clinician's 'Philosopher's Stone'

2001 saw an explosion of interest in stem cells, both in scientific literature and the popular press. Much of this revolved around emotive issues related to manipulation of the pluripotentiality (ability to produce many cell types) of either embryonic or adult stem cells. However, there is still a poor appreciation among the commercial scientific community of the importance of adult tissue stem cells in normal tissue homeostasis and how drugs affect their behaviour. A thorough preclinical evaluation of the effects of potential new drugs on these adult tissue stem cells can reveal mechanisms of action that can significantly improve the efficacy of clinical trials and reduce late stage drug failure.

The Definition and Importance of Stem Cells in Tissue Homeostasis

The fertilised zygote is the ultimate totipotential (capable of making all cell types) stem cell, capable of forming all the differentiated cells and tissues of the body according to strict temporal and spatial controls. The factors that regulate these processes during development are only beginning to be understood. The early divisions of the zygote during development produce further totipotent stem cells and - at least up to the blastocyst stage - cells of the inner cell mass can be isolated, grown and expanded in culture as embryonic stem (ES) cells.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Professor Christopher Potten, Founder of EpiStem Ltd

Professor Christopher Potten is an Emeritus Professor of the UK Cancer Research Campaign, Professor of Stem Cell Biology at Manchester University and a Founder of EpiStem Ltd, a specialist preclinical CRO.

He is a world expert in epithelial stem cell biology and apoptosis, publishing around 400 papers in these areas, and over recent years has assisted many pharmaceutical companies in evaluating their novel anti-cancer and mucositis therapies.

spacer
Professor Christopher Potten
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the 11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

New Temperature Profiles from a Global Study

Laminar Medica

Recently there has been an influx of temperature mapping studies to collect sufficient ambient data to develop temperature profiles.  Solid temperature profiles on specific shipping routes are required to ensure streamlined packaging and robust lane qualification. The most reliable method to develop temperature profiles is to capture the actual reading from shipments, as well as using the historical and meteorological data to increase the confidence level.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement